CHRS
Coherus Oncology, Inc. · Healthcare
Director James Healy sold $8.0M of Coherus Oncology, Inc.
Sold$8,027,600
$22.30Price
360,000Shares
−16%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Fri, Jun 28. Filed Tue, Jul 2. Not investment advice.